Financhill
Sell
35

ATXI Quote, Financials, Valuation and Earnings

Last price:
$1.87
Seasonality move :
-5.13%
Day range:
$1.81 - $1.90
52-week range:
$1.60 - $15.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.43x
Volume:
14.8K
Avg. volume:
36.3K
1-year change:
-86.1%
Market cap:
$3.7M
Revenue:
--
EPS (TTM):
-$21.87

Earnings Data

Next earnings date for ATXI
Mar 18
2025
Most recent earnings per share
-$1.92
Missed by $1.92
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATXI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/18/2025 Q4 -- -- -- -- --
11/14/2024 Q3 -- -- -$1.92 -- --
08/09/2024 Q2 -- -- -$6.43 -- --
05/15/2024 Q1 -- -- -$15.40 -- --
03/18/2024 Q4 -- -- $1.88 -- --
11/13/2023 Q3 -- -- $4.50 -- --
06/30/2023 Q2 -- -- -$38.74 -- --
03/31/2023 Q1 -- -- -$101.57 -- --
12/31/2022 Q4 -- -- $9.03 -- --
09/30/2022 Q3 -- -- -$33.75 -- --
06/30/2022 Q2 -- -- -$30.75 -- --
05/17/2022 Q1 -- -- -$153.75 -- --
02/15/2022 Q4 -- -- -$55.50 -- --
11/04/2021 Q3 -- -- -$59.25 -- --
08/16/2021 Q2 -- -- -$67.50 -- --
05/17/2021 Q1 -- -- -$67.50 -- --
12/31/2020 Q4 -- -- -$67.50 -- --
11/04/2020 Q3 -- -- -$67.50 -- --
08/14/2020 Q2 -- -- -$123.75 -- --
05/11/2020 Q1 -- -- -$90.00 -- --
03/30/2020 Q4 -- -- -$371.25 -- --
11/13/2019 Q3 -- -- -$157.50 -- --
08/14/2019 Q2 -- -- -$483.75 -- --
05/13/2019 Q1 -- -- -$922.50 -- --
03/12/2019 Q4 -- -- -$416.25 -- --
11/14/2018 Q3 -- -- -$281.25 -- --
08/14/2018 Q2 -- -- -$506.25 -- --
05/03/2018 Q1 -- -- -$1,158.75 -- --
03/01/2018 Q4 -- -- -$708.75 -- --
11/09/2017 Q3 -- -- -$337.50 -- --
08/11/2017 Q2 -- -- -$787.50 -- --
03/31/2017 Q1 -- -- -$74.28 -- --
12/31/2016 Q4 -- -- -$103.70 -- --
09/30/2016 Q3 -- -- -$69.22 -- --
06/30/2016 Q2 -- -- -$98.10 -- --
03/31/2016 Q1 -- -- -$133.22 -- --

Avenue Therapeutics Earnings Questions

  • How Much did Avenue Therapeutics Generate in Revenue Last Quarter?

    Avenue Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Avenue Therapeutics Beat Earnings Last Quarter?

    Avenue Therapeutics announced earnings per share of -$1.92 which represents a miss of analyst forecast a -- per share.

  • Is Avenue Therapeutics Profitable?

    Avenue Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Avenue Therapeutics EPS Next Year?

    Avenue Therapeutics's earnings are forecast to grow from -$73.50 per share to -- per share next year representing an increase of --.

  • When is Avenue Therapeutics's Earnings Date?

    Avenue Therapeutics's next earnings date is March 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock